Smithfield Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Smithfield Trust’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15	Closed	-$3K	–	1006
2023 Q3	$3K	Hold	15	–	–	﹤0.01%	949
2023 Q2	$3K	Hold	15	–	–	﹤0.01%	966
2023 Q1	$3K	Hold	15	–	–	﹤0.01%	935
2022 Q4	$3K	Hold	15	–	–	﹤0.01%	930
2022 Q3	$3K	Hold	15	–	–	﹤0.01%	965
2022 Q2	$2K	Hold	15	–	–	﹤0.01%	1031
2022 Q1	$3K	Hold	15	–	–	﹤0.01%	1025
2021 Q4	$3K	Hold	15	–	–	﹤0.01%	1026
2021 Q3	$3K	Hold	15	–	–	﹤0.01%	1052
2021 Q2	$3K	Hold	15	–	–	﹤0.01%	1023
2021 Q1	$2K	Hold	15	–	–	﹤0.01%	1066
2020 Q4	$2K	Hold	15	–	–	﹤0.01%	1053
2020 Q3	$2K	Hold	15	–	–	﹤0.01%	1032
2020 Q2	$2K	Buy	+15	New	+$2.02K	﹤0.01%	953

Other funds holding ALNY

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return